|
Xiao-Dong Li, Hua Shen, Jing-Ting Jiang. Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer [J]. {H}World Journal of Gastroenterology, 2011(8):1082.
|
|
Koizumi W, Narahara H, Hara T. S-1 plus cisplatin versus S-1 alone for first line treatment of advanced gastric cancer(SPIRITS trial):a phase Ⅲ trial [J]. {H}LANCET ONCOLOGY, 2008.215.
|
|
Zang D Y, Yang D H, Kim M J. Dose-finding study of docetaxel oxaliplatin, and S-1 for patients with advanced gastric cancer [J]. {H}Cancer Chemotherapy and Pharmacology, 2009.509.
|
|
Ajani J A, Lee F C, Singh D A. Multicenter phase Ⅱtrial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma [J]. {H}Journal of Clinical Oncology, 2006.663.
|
|
Lenz H J, Lee F C, Haler D G. Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase Ⅱ study [J]. {H}CANCER, 2007.33.
|
|
Koizumi W, Narahara H, Hara T. S-1 plus cisplatin versus S-1 alone for first-line treatment with untreated advancedgastric cancer (SPIRITS trial):a phase Ⅲ trial [J]. {H}LANCET ONCOLOGY, 2008.215.
|
|
AL-BATRAN S E, ATMACA A, HEGEWISCH-BECK-ER S. Phase Ⅱ trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with adanced gastric cancer [J]. {H}Journal of Clinical Oncology, 2004, (10):658.
|
|
Oh S Y, Kwon H C, Jeong S H. A phase Ⅱ study of S-1 and oxaliplatin (SOX) combination chemotherapy as afirst-line therapy for patients with advanced gastric cancer [J]. {H}Investigational New Drugs, 2012(1):350.
|
|
Cunningham D, Rao S, Starling N. Randomised multicentrephase Ⅲ study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric(OG) cancer:The REAL 2 trial [J]. {H}Journal of Clinical Oncology, 2006, (18 Suppl):4017.
|
|
Dank M, Zaluski J, Barone C. Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in1st-line advanced gastric cancer patients [J]. {H}Journal of Clinical Oncology, 2005, (16 Suppl):4003.
|
|
Roth AD, Fazio N, Stupp R. Docetaxel, cisplatin, and fluorouracil;docetaxel and cisplatin;and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma:a randomized phase Ⅱ trial of the Swiss Group for clinical cancer research [J]. {H}Journal of Clinical Oncology, 2007, (22):3217.
|
|
Gadgeel S M, Shields A F, Heilbnm L K. PhaseⅡ study ofpaclitaxeland carboplatin in patients with advanced gastric cancer [J]. {H}American Journal of Clinical Oncology(CCT), 2003(1):37.
|
|
Komek G V, Raderer M, Schull B. Effective combination chemotherapy with paclitaxel and cisplatin with or withput human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer [J]. {H}British Journal of Cancer, 2002, (12):1858.
|
下载:
苏公网安备 32100302010246号
